These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27660493)

  • 1. Pregnancy in women with thalassemia: challenges and solutions.
    Petrakos G; Andriopoulos P; Tsironi M
    Int J Womens Health; 2016; 8():441-51. PubMed ID: 27660493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron overload, cardiac and other factors affecting pregnancy in thalassemia major.
    Tsironi M; Karagiorga M; Aessopos A
    Hemoglobin; 2010 Jun; 34(3):240-50. PubMed ID: 20524814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy and beta-thalassemia: an Italian multicenter experience.
    Origa R; Piga A; Quarta G; Forni GL; Longo F; Melpignano A; Galanello R
    Haematologica; 2010 Mar; 95(3):376-81. PubMed ID: 19903676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy in Thalassemia.
    Origa R; Comitini F
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019019. PubMed ID: 30858957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload in β-thalassemia intermedia: an emerging concern.
    Musallam KM; Cappellini MD; Taher AT
    Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetric care for women with thalassemia.
    Lao TT
    Best Pract Res Clin Obstet Gynaecol; 2017 Feb; 39():89-100. PubMed ID: 28341055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia.
    Carlberg KT; Singer ST; Vichinsky EP
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):297-315. PubMed ID: 29458733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive health in patients with beta-thalassemia.
    Tolis GJ; Vlachopapadopoulou E; Karydis I
    Curr Opin Pediatr; 1996 Aug; 8(4):406-10. PubMed ID: 8954276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience.
    Pinto VM; Poggi M; Russo R; Giusti A; Forni GL
    Blood Rev; 2019 Nov; 38():100594. PubMed ID: 31416718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of thalassemia intermedia.
    Borgna-Pignatti C; Marsella M; Zanforlin N
    Ann N Y Acad Sci; 2010 Aug; 1202():214-20. PubMed ID: 20712795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management.
    Vichinsky E
    Curr Med Res Opin; 2016; 32(1):191-204. PubMed ID: 26479125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron status and oxidative stress in beta-thalassemia patients in Jakarta.
    Laksmitawati DR; Handayani S; Udyaningsih-Freisleben SK; Kurniati V; Adhiyanto C; Hidayat J; Kusnandar S; Dillon HS; Munthe BG; Wirawan R; Soegianto RR; Ramelan W; Freisleben HJ
    Biofactors; 2003; 19(1-2):53-62. PubMed ID: 14757977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the prevention and treatment are changing thalassemia from a fatal to a chronic disease. experience from a Cyprus model and its use as a paradigm for future applications.
    Kolnagou A; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):287-95. PubMed ID: 19814674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron Chelation Therapy as a Modality of Management.
    Aydinok Y
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy in Thalassemia and Sickle Cell Disease: The Experience of an Italian Thalassemia Center.
    Sorrentino F; Maffei L; Caprari P; Cassetta R; Dell'Anna D; Materazzi S; Risoluti R
    Front Mol Biosci; 2020; 7():16. PubMed ID: 32118041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalassemia major and intermedia in jammu and kashmir, India: a regional transfusion centre experience.
    Vasudev R; Sawhney V
    Indian J Hematol Blood Transfus; 2014 Dec; 30(4):297-300. PubMed ID: 25435731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation from a deceased donor with β-thalassemia intermedia is not contraindicated: A case report.
    Gumus E; Abbasoglu O; Tanyel C; Gumruk F; Ozen H; Yuce A
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28211259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.